U.S. Luxury Stock News

NYSE:BABA
NYSE:BABAMultiline Retail

Alibaba (NYSE:BABA) Profit Margins Climb to 12.4%, Reinforcing Bullish Narratives on Valuation

Alibaba Group Holding (NYSE:BABA) just released its Q2 2026 results, reporting revenue of ¥247.8 billion and basic EPS of ¥9.05. Looking over the past year, the company has seen revenue climb from ¥961.9 billion ($129.2 billion) to ¥1,012.1 billion ($135.6 billion), while EPS rose from ¥35.22 to ¥54.10. This reflects notable momentum in recent quarters. Margins have expanded and profit growth has accelerated, positioning the results as a strong talking point for shareholders. See our full...
NasdaqGM:SNT
NasdaqGM:SNTElectronic

Senstar Technologies (SNT): Profit Margin Expansion Reinforces Bullish Narrative Despite Volatile Quarterly Results

Senstar Technologies (SNT) has just reported its Q3 2025 results, posting revenue of $9.5 million and basic EPS of $0.043. Looking at recent trends, the company has seen revenue move from $8.3 million in Q2 2024 to $10.2 million in Q4 2024 before settling at $9.5 million this quarter. Basic EPS over the same period shifted from $0.021 to $0.068 and now $0.043. These results came alongside firm profit margins, setting the tone for how investors may interpret the quality of earnings this...
NYSE:DKS
NYSE:DKSSpecialty Retail

Dick’s Sporting Goods (DKS): Margin Squeeze Challenges Bullish Narratives Despite 12.7% Revenue Growth

DICK'S Sporting Goods (DKS) has just reported Q3 2026 results with revenue reaching $4.2 billion and net income at $75.2 million, resulting in a quarterly EPS of $0.88. The company has seen revenue increase from $3.1 billion in Q3 2025 to $4.2 billion in Q3 2026, with same store sales growth of 5.7% over the latest quarter. However, margins have tightened compared to last year, adding a note of caution to what investors might otherwise view as a strong set of headline numbers. See our full...
NasdaqGS:EXC
NasdaqGS:EXCElectric Utilities

Does Exelon’s Recent 23.7% Rise Signal a Fair Price in 2025?

Ever wondered if Exelon stock lives up to its buzz, or if the current price actually offers value? You are not alone. Investors are watching closely to decide if now is the right moment to get in or hold back. Stocks do not move for no reason. Exelon certainly caught attention with a 2.2% gain in the last week, helping power an impressive 23.7% year-to-date climb and a striking 87.5% surge over the past five years. That momentum did not appear out of thin air. Recent sector-wide optimism and...
NasdaqGS:NBIS
NasdaqGS:NBISSoftware

Is Nebius Group Fairly Priced After 24.5% Drop and Product Expansion News?

Thinking about whether Nebius Group is fairly priced? Let’s take a closer look at what has been driving interest, as well as what could matter for investors evaluating the stock’s value. The stock has kept traders active, with a recent 24.5% slide over the past month. Despite this, it remains up 210.4% year-to-date and 341.9% over the past 12 months. There has been ongoing news about Nebius Group’s ambitious product expansion plans and growing partnerships, capturing the attention of both...
NasdaqGS:NTNX
NasdaqGS:NTNXSoftware

Nutanix (NTNX) Net Profit Margin Turns Positive, Challenging Cautious Narratives on Profit Sustainability

Nutanix (NTNX) just reported its Q1 2026 results, posting revenue of $670.6 million and basic EPS of $0.23, with net income hitting $62.1 million. Looking at recent quarters, the company has seen revenue climb from $547.9 million in Q4 2024 to $670.6 million in the latest period. Basic EPS turned positive after a previous loss of -$0.51 in Q4 2024. Margins have shown notable resilience, setting a solid foundation for this latest release. See our full analysis for Nutanix. Next, we will see...
NYSE:BBY
NYSE:BBYSpecialty Retail

Best Buy (BBY): Net Margin Falls to 1.5%, Challenging Bullish Recovery Narratives

Best Buy (BBY) has just released its Q3 2026 results, reporting $9.7 billion in revenue and basic EPS of $0.66, with net income of $140 million. Looking at prior periods, quarterly revenue has increased from $8.8 billion in Q1 to $9.4 billion in Q2 and now stands at $9.7 billion, while EPS has declined from $0.95 in Q1 and $0.88 in Q2. As investors examine these results, factors such as compressed margins and the relationship between sales growth and earnings will likely attract attention...
NYSE:GOTU
NYSE:GOTUConsumer Services

Gaotu Techedu (NYSE:GOTU) Net Loss Narrows Further, Supporting Bullish Turnaround Narratives

Gaotu Techedu (NYSE:GOTU) just released its Q3 2025 results, recording revenue of ¥1.6 billion and a basic EPS of -¥0.61. For context, the company’s revenue has climbed from ¥1.0 billion in Q2 2024 to ¥1.6 billion this quarter. Basic EPS has improved from -¥1.65 in Q2 2024. Investors will be watching how the company works to narrow its losses and maintain the current pace of revenue growth as margins remain in focus this quarter. See our full analysis for Gaotu Techedu. Now that the headline...
NYSE:SJM
NYSE:SJMFood

J. M. Smucker (SJM) Swings to $241M Q2 Profit, Challenging Persistent Loss Narratives

J. M. Smucker (SJM) just reported results for Q2 2026, notching revenue of $2.3 billion and basic EPS of $2.26, with net income for the period coming in at $241.3 million. Over the past few quarters, revenue has hovered near the $2.1 to $2.3 billion mark while EPS has fluctuated, with recent periods swinging from negative to positive territory. Investors will be weighing these headline numbers in the context of volatile earnings margins as the company aims for sustained profitability. See our...
NasdaqGS:WOOF
NasdaqGS:WOOFSpecialty Retail

Petco (WOOF) Same Store Sales Decline Challenges Community Turnaround Narratives

Petco Health and Wellness Company (WOOF) just reported Q3 2026 financials, posting revenue of $1.5 billion and basic EPS of $0.03. Over the past year, the company has seen revenue move from $6.2 billion to $6.0 billion with EPS tracking from -$4.95 to -$0.01, highlighting recent volatility in earnings. Margins remain under pressure, keeping the conversation tightly focused on the company’s path toward profitability. See our full analysis for Petco Health and Wellness Company. Next, we will...
NasdaqGS:AMWD
NasdaqGS:AMWDBuilding

American Woodmark (AMWD) Net Profit Margin Drops to 3.9%, Challenging Durable Earnings Narrative

American Woodmark (AMWD) just posted its Q2 2026 results, reporting revenue of $394.6 million and basic EPS of $0.42. Looking back, the company has seen revenue slide from $452.5 million in Q2 2025 to $394.6 million this quarter. EPS dropped from $1.81 to $0.42 over the same period. Margins compressed in the latest quarter, putting profitability in the spotlight for investors. See our full analysis for American Woodmark. Next up, we will compare these results with prevailing narratives to see...
NasdaqGS:ATAT
NasdaqGS:ATATHospitality

Atour (NasdaqGS:ATAT) Net Margin Decline Challenges Bullish Growth Narrative Despite 20% Revenue Increase

Atour Lifestyle Holdings (NasdaqGS:ATAT) just released its Q3 2025 results, reporting revenue of ¥2.6 billion and basic EPS of ¥3.41. Over the past year, the company has seen revenue climb from ¥6.1 billion to ¥9.1 billion, up 20.4%, while EPS increased from ¥7.57 to ¥10.62, a 26.2% gain. Although net profit margins narrowed slightly compared to last year, the topline and EPS growth indicate the business is still delivering for shareholders. See our full analysis for Atour Lifestyle...
NYSE:CBRE
NYSE:CBREReal Estate

Should Investors Reconsider CBRE After Major Property Acquisitions and a 25% Rally in 2025?

Thinking about whether CBRE Group offers real value right now? You are not alone, as more investors are questioning if the impressive run can last or if the stock has become too expensive. CBRE Group has shown strong performance lately, climbing 6.9% in just the past week, up 24.9% year-to-date, and delivering a massive 162.3% over the last 5 years. Market enthusiasm for CBRE Group has been fueled by a string of headline deals and sector momentum, including increased activity in commercial...
NasdaqGS:ADI
NasdaqGS:ADISemiconductor

Analog Devices (ADI) Profit Margin Jumps to 20.6%, Reinforcing Bullish Narratives on Earnings Quality

Analog Devices (ADI) just posted its FY 2025 fourth-quarter results, reporting revenue of $3.1 billion and basic EPS of $1.60. Over the past year, the company has seen revenue rise from $9.4 billion to $11.0 billion and basic EPS climb from $3.30 to $4.59. With margins now at 20.6%, investors will be watching how the company leverages improved profitability going forward. See our full analysis for Analog Devices. Let's see how the fresh results line up with the prevailing narratives in the...
NasdaqGM:JFIN
NasdaqGM:JFINConsumer Finance

Jiayin Group (NasdaqGM:JFIN) Margins Jump to 26.2%, Reinforcing Bullish Profitability Narratives

Jiayin Group (NasdaqGM:JFIN) posted total revenue of ¥1.47 billion and basic EPS of ¥7.34 for the third quarter of 2025, accompanied by a net income of ¥376.49 million. The company has seen revenue move from ¥1.44 billion in Q3 2024 to ¥1.47 billion in Q3 2025, while EPS climbed from ¥5.07 to ¥7.34 over the same period. These results point to expanding margins and a favorable profit backdrop heading into the next reporting cycle. See our full analysis for Jiayin Group. Next up, we’re...
NasdaqGS:ZS
NasdaqGS:ZSSoftware

Zscaler (ZS) Posts Q1 Loss as Net Margins Remain Negative, Challenging Profitability Narrative

Zscaler (ZS) just released its Q1 2026 results, posting revenue of $788.1 million and a basic EPS of -$0.07. Looking at recent trends, the company has seen total revenue increase steadily from $592.9 million in Q4 2024 to $788.1 million in Q1 2026. EPS figures have remained negative during this period. Profitability has not yet been achieved, but the latest results may prompt investors to focus on the company’s potential for a margin turnaround in the upcoming quarters. See our full analysis...
NYSE:SB
NYSE:SBShipping

Safe Bulkers (SB) Margin Compression Challenges Bullish Outlook After Q3 Net Profit Margin Declines to 13.9%

Safe Bulkers (SB) has just released its Q3 2025 results, reporting total revenue of $73.1 million and basic EPS of $0.15, with net income of $15.8 million for the quarter. The company has seen revenue fluctuate over the past several quarters, decreasing from $78.5 million in Q2 2024 to a low of $64.3 million in Q1 2025 before rebounding this quarter. EPS also moved from $0.24 in Q2 2024 to a modest loss in Q2 2025, before returning to positive territory. Margins have compressed over the last...
NYSE:DELL
NYSE:DELLTech

Dell Technologies (DELL): Net Profit Margin Rises to 5%, Reinforcing Bullish Earnings Narratives

Dell Technologies (DELL) just published its Q3 2026 results, posting revenue of $27.0 billion and basic EPS of $2.28. The company has seen revenue trend from $24.4 billion in Q3 last year to over $29.8 billion in Q2 and now $27.0 billion this quarter. EPS has moved from $1.61 a year ago to $2.36 in Q4 and $2.28 now. Solid profit margins and steady earnings trends continue to shape an intriguing picture for investors eyeing Dell's financial momentum. See our full analysis for Dell...
NYSE:LUCK
NYSE:LUCKHospitality

A Closer Look at Lucky Strike Entertainment’s (LUCK) Valuation Following a Recent 3% Share Price Move

Lucky Strike Entertainment (LUCK) shares moved 3% higher today, catching some attention from investors. While there wasn’t a high-profile catalyst, moves like this often have traders checking for clues about shifting sentiment or potential upcoming announcements. See our latest analysis for Lucky Strike Entertainment. While Lucky Strike Entertainment’s latest 3% jump puts some spark back in the share price, longer-term momentum has been mixed. The 7-day share price return of 8.3% suggests...
NasdaqGM:RNA
NasdaqGM:RNABiotechs

Will FDA Accelerated Pathway for Delpacibart Zotadirsen Reshape Avidity Biosciences' (RNA) Rare Disease Trajectory?

In November 2025, Avidity Biosciences announced the launch of its Managed Access Program for the investigational therapy delpacibart zotadirsen for eligible Duchenne muscular dystrophy (DMD44) patients in the United States, aligning with the FDA on a 2026 accelerated approval submission pathway. This move reflects significant clinical and regulatory progress, as the therapy has earned multiple expedited designations from both U.S. and European regulators. We'll explore how securing FDA...
NYSE:EL
NYSE:ELPersonal Products

3 Stocks That May Be Trading Below Their Estimated Value

As the U.S. stock market experiences a notable upswing with major indexes like the Nasdaq, S&P 500, and Dow Jones Industrial Average showing significant gains entering the Thanksgiving holiday, investors are increasingly attentive to opportunities that may be trading below their estimated value. In such a buoyant environment, identifying stocks that are potentially undervalued can provide investors with strategic entry points to capitalize on broader market optimism while maintaining a focus...
NasdaqGS:GDRX
NasdaqGS:GDRXHealthcare Services

GoodRx Holdings And 2 Other Promising Penny Stocks

As the U.S. stock market continues its upward trajectory, with major indexes marking their biggest weekly rise since June, investors are increasingly exploring diverse opportunities to capitalize on this momentum. Penny stocks, a term that may seem outdated yet remains significant, represent smaller or newer companies that can potentially offer substantial returns when they are built on solid financial foundations. In this article, we will explore three penny stocks that exhibit strong...
NasdaqGM:NBN
NasdaqGM:NBNBanks

US Market's Undiscovered Gems With Promising Potential

As major U.S. stock indices, including the Dow Jones, Nasdaq, and S&P 500, continue to experience gains entering the Thanksgiving holiday week, investors are keenly observing market dynamics that could impact small-cap stocks. With economic indicators showing mixed signals and broader market sentiment fluctuating, identifying promising yet lesser-known stocks becomes crucial for those looking to capitalize on potential opportunities in a dynamic environment.